BioCentury
ARTICLE | Financial News

Akeso raises $45M in series B

September 1, 2017 3:18 PM UTC

On Aug. 28, Akeso Biopharma Inc. (Zhongshan, China) raised RMB300 million ($45.2 million) in a series B round led by Shenzhen GTJA Investment Group. Existing investors Shenzhen Capital, Qianhai Parent Fund and Qianhai TRI Wise Capital also participated...

BCIQ Company Profiles

Akeso Inc.